These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 20920697)

  • 41. High rates of quinolone resistance among urinary tract infections in the ED.
    Khawcharoenporn T; Vasoo S; Ward E; Singh K
    Am J Emerg Med; 2012 Jan; 30(1):68-74. PubMed ID: 21075586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic.
    Skiest D; Brown K; Hester J; Moore T; Crosby C; Mussa HR; Hoffman-Roberts H; Cooper T
    HIV Med; 2006 Sep; 7(6):361-8. PubMed ID: 16903980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections.
    Frazee BW; Lynn J; Charlebois ED; Lambert L; Lowery D; Perdreau-Remington F
    Ann Emerg Med; 2005 Mar; 45(3):311-20. PubMed ID: 15726056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.
    Chierakul W; Anunnatsiri S; Short JM; Maharjan B; Mootsikapun P; Simpson AJ; Limmathurotsakul D; Cheng AC; Stepniewska K; Newton PN; Chaowagul W; White NJ; Peacock SJ; Day NP; Chetchotisakd P
    Clin Infect Dis; 2005 Oct; 41(8):1105-13. PubMed ID: 16163628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus.
    Cenizal MJ; Skiest D; Luber S; Bedimo R; Davis P; Fox P; Delaney K; Hardy RD
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2628-30. PubMed ID: 17502411
    [TBL] [Abstract][Full Text] [Related]  

  • 46. No decrease in clindamycin susceptibility despite increased use of clindamycin for pediatric community-associated methicillin-resistant Staphylococcus aureus skin infections.
    Szczesiul JM; Shermock KM; Murtaza UI; Siberry GK
    Pediatr Infect Dis J; 2007 Sep; 26(9):852-4. PubMed ID: 17721387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons.
    Crum-Cianflone NF; Burgi AA; Hale BR
    Int J STD AIDS; 2007 Aug; 18(8):521-6. PubMed ID: 17686212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Crawford SE; David MZ; Glikman D; King KJ; Boyle-Vavra S; Daum RS
    J Am Board Fam Med; 2009; 22(6):647-54. PubMed ID: 19897693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of administrative healthcare claims to examine the effectiveness of trimethoprim-sulfamethoxazole versus fluoroquinolones in the treatment of community-acquired acute pyelonephritis in women.
    Carrie AG; Metge CJ; Collins DM; Harding GK; Zhanel GG
    J Antimicrob Chemother; 2004 Mar; 53(3):512-7. PubMed ID: 14749344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Community-acquired methicillin-resistant Staphylococcus aureus infections of the hand: prevalence and timeliness of treatment.
    O'Malley M; Fowler J; Ilyas AM
    J Hand Surg Am; 2009 Mar; 34(3):504-8. PubMed ID: 19258149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran.
    Askarian M; Zeinalzadeh A; Japoni A; Alborzi A; Memish ZA
    Int J Infect Dis; 2009 Sep; 13(5):e241-7. PubMed ID: 19269873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
    Guneysel O; Onur O; Erdede M; Denizbasi A
    J Emerg Med; 2009 May; 36(4):338-41. PubMed ID: 18325714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles.
    Miller LG; Perdreau-Remington F; Rieg G; Mehdi S; Perlroth J; Bayer AS; Tang AW; Phung TO; Spellberg B
    N Engl J Med; 2005 Apr; 352(14):1445-53. PubMed ID: 15814880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers.
    Ellis MW; Hospenthal DR; Dooley DP; Gray PJ; Murray CK
    Clin Infect Dis; 2004 Oct; 39(7):971-9. PubMed ID: 15472848
    [TBL] [Abstract][Full Text] [Related]  

  • 56. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
    Caterino JM; Weed SG; Espinola JA; Camargo CA
    Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections.
    Kourbatova EV; Halvosa JS; King MD; Ray SM; White N; Blumberg HM
    Am J Infect Control; 2005 Sep; 33(7):385-91. PubMed ID: 16153484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
    J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.
    Wang JL; Chen SY; Wang JT; Wu GH; Chiang WC; Hsueh PR; Chen YC; Chang SC
    Clin Infect Dis; 2008 Mar; 46(6):799-806. PubMed ID: 18266610
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic selection for purulent skin and soft-tissue infections in ambulatory care: a decision-analytic approach.
    Hersh AL; Weintrub PS; Cabana MD
    Acad Pediatr; 2009; 9(3):179-84. PubMed ID: 19450778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.